Alpha-fetoprotein gene polymorphisms and risk of HCC and cirrhosis

Clinica Chimica Acta

Volumn 411, Issue 5-6, 2010, Pages 351-358

  Suriapranata, Ivet M ^a   Sudania, Widyartini Made ^a   Tjong, Wen Ye ^a   Suciptan, Adi A ^a   Gani, Rino A ^b   Hasan, Irsan ^b   Sanityoso, Andri ^b   Budihusodo, Unggul ^b   Miskad, Upik A ^c   Akil, Fardah ^c   Lelosutan, Syafruddin A R ^d   Martamala, Ruswhandi ^d   Yusuf, Irawan ^c   Lesmana, Laurentius A ^b   Sulaiman, Ali ^e   Tai, Susan ^a  

^a Mochtar Riady Institute for Nanotechnology   (Indonesia)

^b CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^c Wahidin Hospital   (Indonesia)

^d Gatot Soebroto Hospital   (Indonesia)

^e Klinik Hati   (Indonesia)

Author keywords

AFP; Cirrhosis; HCC; SNP

Indexed keywords

ALPHA FETOPROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC GROUP; EXON; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDONESIAN; INTRON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC VARIATION; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 75149136560     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.11.030     Document Type: Article

References (58)

1. Feitelson M.A. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett 239 (2006) 10-20
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis 11 (2004) 97-107
3. Merican I., Guan R., Amarapuka D., et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15 (2000) 1356-1361
4. World Health Organization. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepatitis 6 (1999) 35-47
5. Wang B.E., Ma W.M., Sulaiman A., et al. Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries. J Med Virol 67 3 (2002) 394-400
6. World Health Organization. Global prevalence of hepatitis A, B, and C. Wkly Epidemiol Rec 77 (2002) 6
7. Goldman R., Ressom H.W., Varghese R.S., et al. Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res 15 5 (2009) 1808-1813
8. Farinati F., Marino D., De Giorgio M., et al. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?. Am J Gastroenterol 101 (2006) 524-532
9. Carlini P., Ferranti P., Polizio F., Ciriolo M.R., and Rotilio G. Purification and characterization of alpha-fetoprotein from the human hepatoblastoma HepG2 cell line in serum-free medium. Biometals 20 (2007) 869-878
10. Dudich E., Semenkova L., Dudich I., Denesyuk A., Tatulov E., and Korpela T. Alpha-fetoprotein antagonizes X-linked inhibitor of apoptosis protein anticaspase activity and disrupts XIAP-caspase interaction. FEBS J 273 (2006) 3837-3849
11. Dudich E., Semenkova L., Dudich I., et al. Alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases. Eur J Biochem 266 (1999) 750-761
12. Semenkova L.N., Dudich E.I., and Dudich I.V. Induction of apoptosis in human hepatoma cells by alpha-fetoprotein. Tumour Biol 18 (1997) 261-273
13. Li M.S., Li P.F., Yang F.Y., He S.P., Du G.G., and Li G. The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Res 12 (2002) 151-156
14. Wang X.W., and Xu B. Stimulation of tumor-cell growth by alpha-fetoprotein. Int J Cancer 75 (1998) 596-599
15. Wang X.W., and Xie H. Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro. Life Sci 64 (1999) 17-23
16. Dudich E., Semenkova L., Gorbatova E., et al. Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumour Biol 19 (1998) 30-40
17. Yang X., Zhang Y., Zhang L., Zhang L., and Mao J. Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cells. Cancer Lett 271 (2008) 281-293
18. Li M., Li H., Li C., Zhou S., Guo L., et al. Alpha fetoprotein is a novel protein-binding partner for caspase-3 and blocks the apoptotic signaling pathway in human hepatoma cells. Int J Cancer 124 12 (2009) 2845-2854
19. Li M., Li H., Li C., Guo L., Liu H., et al. Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells. Cancer Lett 285 2 (2009) 190-199
20. Saito S., Ojima H., Ichikawa H., Hirohashi S., and Kondo T. Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis. Cancer Sci 99 (2008) 2402-2409
21. Nakabayashi H., Koyama Y., Suzuki H., et al. Functional mapping of tissue-specific elements of the human alpha-fetoprotein gene enhancer. Biochem Biophys Res Commun 318 (2004) 773-785
22. Nakabayashi H., Hashimoto T., Miyao Y., Tjong K.K., Chan J., and Tamaoki T. A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma. Mol Cell Biol 11 (1991) 5885-5893
23. Sawadaishi K., Morinaga T., and Tamaoki T. Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of the human alpha-fetoprotein and albumin genes. Mol Cell Biol 8 (1988) 5179-5187
24. Chen G.G., Ho R.L., Wong J., Lee K.F., and Lai P.B. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC). Eur J Surg Oncol 33 (2007) 882-886
25. Barett C.J., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
26. Miller J.C., and Lee S.I. Screening for hepatocellular cancer in cirrhotic patients. Radiol Rounds 3 (2005) 102-109
27. Myles S., Davision D., Barrett J., Stoneking M., and Timpson N. Worldwide population differentiation at disease-associated SNPs. BMC Med Genomics 1 (2008) 22
28. Vacher J., and Tilghman S.M. Dominant negative regulation of the mouse alpha-fetoprotein gene in adult liver. Science 250 (1990) 1732-1735
29. Heinemeyer T., Wingender E., Reuter I., et al. Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL. Nucleic Acids Res 26 (1998) 364-370
30. Quandt K., Frech K., Karas H., Wingender E., and Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23 (1995) 4878-4884
31. Ogden S.K., Lee K.C., Wernke-Dollries K., Stratton S.A., Aronow B., and Barton M.C. p53 targets chromatin structure alteration to repress alpha-fetoprotein gene expression. J Biol Chem 276 (2001) 42057-42062
32. Lee K.C., Crowe A.J., and Barton M.C. p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol Cell Biol 19 (1999) 1279-1288
33. Crowe A.J., Sang L., Li K.K., Lee K.C., Spear B.T., and Barton M.C. Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the alpha-fetoprotein gene. J Biol Chem 274 (1999) 25113-25120
34. Cui R., Nguyen T.T., Taube J.H., Stratton S.A., Feuerman M.H., and Barton M.C. Family members p53 and p73 act together in chromatin modification and direct repression of {alpha}-fetoprotein transcription. J Biol Chem 280 (2005) 39152-39160
35. Nguyen T.T., Cho K., Stratton S.A., and Barton M.C. Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene. Mol Cell Biol 25 6 (2005) 2147-2157
36. Reese M.G., Eeckman F.H., Kulp D., and Haussler D. Improved splice site detection in Genie. J Comput Biol 4 (1997) 311-323
37. Pertea M., Lin X., and Salzberg S.L. GeneSplicer: a new computational method for splice site prediction. Nucleic Acids Res 29 (2001) 1185-1190
38. Rogozin I.B., and Milanesi L. Analysis of donor splice signals in different organisms. J Mol Evol 45 (1997) 50-59
39. Hebsgaard S.M., Korning P.G., Tolstrup N., Engelbrecht J., Rouze P., and Brunak S. Splice site prediction in Arabidopsis thaliana DNA by combining local and global sequence information. Nucleic Acids Res 24 (1996) 3439-3452
40. Brunak S., Engelbrecht J., and Knudsen S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol 220 (1991) 49-65
41. Lee P.H., and Shatkay H. Ranking single nucleotide polymorphisms by potential deleterious effects. AMIA Annu Symp Proc 2008 (2008) 667-671
42. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 136 (2009) 215-233
43. Slack F.J., and Weidhaas J.B. MicroRNA in cancer prognosis. N Engl J Med 18 359(25 (2008) 2720-2722
44. Esquela-Kerscher A., and Slack F.J. Oncomirs - microRNA with a role in cancer. Nat Rev Cancer 6 (2006) 259-269
45. Yu Z., Li Z., Jolicoeur N., et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res 35913 (2007) 4535-4541
46. Chin L.J., Ratner E., Leng S., et al. A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res 68 20 (2008) 8535-8540
47. Tchatchou S., Jung A., Hemminki K., et al. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 30 1 (2009) 59-64
48. Landi D., Gemignani F., Naccarati A., et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 29 3 (2008) 579-584
49. Brendle A., Lei H., Brandt A., et al. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis 29 7 (2008) 1394-1399
50. Landi D., Gemignani F., Naccarati A., et al. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 29 (2008) 579-584
51. Christensen B.C., Moyer B.J., Avissar M., et al. A let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers. Carcinogenesis 30 6 (2009) 1003-1007
52. Griffiths-Jones S., Saini H.K., van Dongen S., and Enright A.J. miRbase: tools for microRNA genomics. Nucleic Acids Res 36 (2008) D154-D158 Database Issue
53. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., and Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34 (2006) D140-D144 Database Issue
54. Betel D., Wilson M., Gabow A., Marks D.S., and Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 36 (2008 Jan) D149-D153 Database Issue
55. Krek A., Grün D., Poy M.N., et al. Combinatorial microRNA target predictions. Nat Genet 37 (2005) 495-500
56. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
57. Grimson A., Farh K., Johnston W.K., Garrett-Engele P., Lim L.P., and Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27 (2007) 91-105
58. Friedman R.C., Farh K., Burge C.B., and Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19 (2009) 92-105